Co-Authors
This is a "connection" page, showing publications co-authored by Fabrice Barlesi and Jean-Marie Michot.
Connection Strength
0.636
-
Severe COVID-19 in patients with hematological cancers presenting with viremia. Ann Oncol. 2021 10; 32(10):1297-1300.
Score: 0.239
-
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. Ann Oncol. 2020 07; 31(7):961-964.
Score: 0.219
-
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies. Ann Oncol. 2021 11; 32(11):1445-1447.
Score: 0.060
-
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic. Cancer Cell. 2021 08 09; 39(8):1039-1041.
Score: 0.059
-
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021 03 11; 12(3):258.
Score: 0.058